| Sep 18 |
BeiGene’s TEVIMBRA gains approval for OSCC in Israel
|
| Sep 17 |
BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy
|
| Sep 13 |
BeiGene Singapore Raises Awareness for World Lymphoma Awareness Day 2024: It's Time for Honest Talk
|
| Sep 12 |
SK hynix And 2 More Stocks Estimated To Be Trading Below Fair Value
|
| Sep 12 |
Oxford Industries Reports Weak Results, Joins Viper Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
|
| Sep 12 |
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
|
| Sep 9 |
BeiGene Announces Updates to Commercial Leadership Team
|
| Sep 9 |
BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024
|
| Aug 28 |
Wall Street Analysts See a 27.84% Upside in BeiGene (BGNE): Can the Stock Really Move This High?
|
| Aug 28 |
3 US Stocks That Could Be Trading At A Discount
|
